PA8513301A1 - TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR - Google Patents

TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR

Info

Publication number
PA8513301A1
PA8513301A1 PA20018513301A PA8513301A PA8513301A1 PA 8513301 A1 PA8513301 A1 PA 8513301A1 PA 20018513301 A PA20018513301 A PA 20018513301A PA 8513301 A PA8513301 A PA 8513301A PA 8513301 A1 PA8513301 A1 PA 8513301A1
Authority
PA
Panama
Prior art keywords
inhibitor
sodium
type
hydrogen exchanger
nhe
Prior art date
Application number
PA20018513301A
Other languages
Spanish (es)
Inventor
Weichao George Chen
Eric David Cox
Angel Guzman-Perez
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PA8513301A1 publication Critical patent/PA8513301A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN INHIBIDOR DE NHE-1, METODOS PARA UTILIZAR EL INHIBIDOR DE NHE-1 Y COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL INHIBIDOR DE NHE-1. EL INHIBIDOR DE NHE-1 ES UTIL PARA LA REDUCCION DE LAS LESIONES TISULARES RESULTANTES DE LA ISQUEMIA DE LOS TEJIDOS.AN NHE-1 INHIBITOR, METHODS FOR USING THE NHE-1 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE NHE-1 INHIBITOR. THE NHE-1 INHIBITOR IS USEFUL FOR THE REDUCTION OF THE TISSULAR INJURIES RESULTING FROM THE TISSUE ISCHEMIA.

PA20018513301A 2000-04-28 2001-03-12 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR PA8513301A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
PA8513301A1 true PA8513301A1 (en) 2003-09-05

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018513301A PA8513301A1 (en) 2000-04-28 2001-03-12 TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR

Country Status (40)

Country Link
EP (1) EP1276737A1 (en)
JP (1) JP2003531900A (en)
KR (1) KR20020093079A (en)
CN (1) CN1225466C (en)
AP (1) AP2002002651A0 (en)
AR (1) AR028375A1 (en)
AU (1) AU2001235896A1 (en)
BG (1) BG107139A (en)
BR (1) BR0110268A (en)
CA (1) CA2407535A1 (en)
CO (1) CO5221125A1 (en)
CR (1) CR6797A (en)
CZ (1) CZ20023408A3 (en)
DZ (1) DZ3310A1 (en)
EA (1) EA004882B1 (en)
EE (1) EE200200615A (en)
GT (1) GT200100064A (en)
HN (1) HN2001000042A (en)
HR (1) HRP20020851A2 (en)
HU (1) HUP0300651A2 (en)
IL (1) IL152075A0 (en)
IS (2) IS6567A (en)
MA (1) MA26897A1 (en)
MX (1) MXPA02010600A (en)
MY (1) MY133842A (en)
NO (1) NO20025132L (en)
NZ (1) NZ521348A (en)
OA (1) OA12256A (en)
PA (1) PA8513301A1 (en)
PE (1) PE20011270A1 (en)
PL (1) PL357765A1 (en)
SK (1) SK14872002A3 (en)
SV (1) SV2002000418A (en)
TN (1) TNSN01065A1 (en)
TR (1) TR200202439T2 (en)
UA (1) UA73348C2 (en)
UY (1) UY26680A1 (en)
WO (1) WO2001083470A1 (en)
YU (1) YU79602A (en)
ZA (1) ZA200208605B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03006872A (en) * 2001-01-31 2003-11-13 Pfizer Prod Inc Ethanolates of sodium-hydrogen exchanger type-1 inhibitor.
CA2469305A1 (en) * 2001-12-19 2003-06-26 Frank Robert Busch Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (en) * 2002-06-03 2004-07-16 Aventis Pharma Sa ISOINDOLONE DERIVATIVES, PREPARATION METHOD AND INTERMEDIARY THEREOF AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME
ES2220185B1 (en) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas NEW INHIBITOR PEPTIDE OF THE NA + / H + EXCHANGER (PINHE), AND ITS APPLICATIONS.
US7550480B2 (en) * 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
RU2518741C1 (en) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" MEDICATION, INHIBITING Na+/H+-EXCHANGE, AND HALOGENIDES OF 1-DIALKYLAMINOETHYL-3-[SUBSTITUTED(DISUBSTITUTED)PHENACYL]-2-AMINOBENZIMIDAZOLIUM

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1056729B1 (en) * 1998-02-27 2004-12-29 Pfizer Products Inc. N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl]guanidine derivatives for the treatment of ischemia

Also Published As

Publication number Publication date
EA200201023A1 (en) 2003-02-27
MA26897A1 (en) 2004-12-20
YU79602A (en) 2006-05-25
ZA200208605B (en) 2003-10-24
OA12256A (en) 2003-11-06
AU2001235896A1 (en) 2001-11-12
UA73348C2 (en) 2005-07-15
GT200100064A (en) 2002-03-22
IL152075A0 (en) 2003-05-29
HRP20020851A2 (en) 2005-02-28
CR6797A (en) 2004-05-17
EP1276737A1 (en) 2003-01-22
TR200202439T2 (en) 2003-02-21
SK14872002A3 (en) 2004-03-02
UY26680A1 (en) 2001-12-28
CN1225466C (en) 2005-11-02
NZ521348A (en) 2004-09-24
EE200200615A (en) 2004-04-15
HN2001000042A (en) 2001-07-09
BG107139A (en) 2003-07-31
DZ3310A1 (en) 2001-11-07
WO2001083470A1 (en) 2001-11-08
CZ20023408A3 (en) 2004-01-14
CA2407535A1 (en) 2001-11-08
CO5221125A1 (en) 2002-11-28
EA004882B1 (en) 2004-08-26
NO20025132L (en) 2002-12-12
AP2002002651A0 (en) 2002-12-31
AR028375A1 (en) 2003-05-07
IS6588A (en) 2002-10-21
MY133842A (en) 2007-11-30
JP2003531900A (en) 2003-10-28
BR0110268A (en) 2003-12-30
MXPA02010600A (en) 2003-03-10
PE20011270A1 (en) 2001-12-12
HUP0300651A2 (en) 2003-07-28
KR20020093079A (en) 2002-12-12
IS6567A (en) 2002-09-24
SV2002000418A (en) 2002-07-03
TNSN01065A1 (en) 2005-11-10
CN1426404A (en) 2003-06-25
PL357765A1 (en) 2004-07-26
NO20025132D0 (en) 2002-10-25

Similar Documents

Publication Publication Date Title
PA8468401A1 (en) COMPOUNDS FOR THE TREATMENT OF ISCHEMIA
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
ES2145638T3 (en) NEW AZOIC COMPOUNDS, USE FOR STAINING, CONTAINING COMPOSITIONS AND STAINING PROCEDURES.
GT199900150A (en) 1,2,3,4-TETRAHYDROQUINOLINS 2-SUBSTITUTED 4-CARBOXYAMIN SUBSTITUTED.
ES2157027T3 (en) OXAZOLIDINONES REPLACED AND ITS USE AS ANTIBACTERIAL PHARMACOS.
BR9913745A (en) Pyridine ketones useful as herbicides
ECSP055747A (en) CGRP ANTAGONISTS ELECTED, PROCEDURE FOR PREPARATION, AS WELL AS ITS EMPLOYMENT AS MEDICATIONS
GT199900067A (en) NEW 4-PHENYLPIPERIDINES FOR THE TREATMENT OF PRURTIC DEDERMATOSIS.
ES2179337T3 (en) DISIAFUROS DE TRIAZOLILO.
AR029837A1 (en) SUBSTITUTED SULPHONIC ACID ANILIDS
PA8586801A1 (en) HIV-INTEGRESS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
AR018162A1 (en) SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
PA8513301A1 (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR
AR030537A1 (en) ANTIBACTERIAL CHINOLINCARBOXILIC AND NAFTIRIDINCARBOXILIC ACIDS
AR025796A1 (en) QUINAZOLINONAS
PA8466101A1 (en) THERAPEUTIC AGENTS
ES2164765T3 (en) HETEROCICLILBENZONITRILOS.
GT199900113A (en) FKBP INHIBITORS.
ES2189072T3 (en) NEW BENZO-HETEROCICLIC CYCLALKINS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
AR006675A1 (en) 4-BENZOILISOTIAZOLES HERBICIDES, PROCEDURE TO OBTAIN THEM, THE HERBICIDES COMPOSITIONS THAT CONTAIN THEM AND THE PROCEDURE OF APPLICATION OF SUCH COMPOUNDS.
AR025797A1 (en) QUINAZOLINONAS
TR200201167T2 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
UY26417A1 (en) TYPE 1 SODIUM-HYDROGEN EXCHANGER INHIBITOR CRYSTALS